Image

Targeted Navigation in Hepatocellular Carcinoma (HCC)

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The investigators are trying to learn more about the personal perceptions and experiences regarding the needs of patients with liver cancer to help improve the care of all patients. The investigators would like to know whether there are needs that patients have or are aware of, especially those needs that the investigators have not been able to address. The investigators aim to develop a program that helps participants and participant's families to navigate the process of being diagnosed with liver cancer and receiving treatment.

Eligibility

Inclusion Criteria:

  • HCC Patients:
    • Enrolled or eligible for enrollment in Unified Prospective Registry and Biorepository of Patients with Chronic Liver Disease or Hepatobiliary Cancers Including Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.
    • Diagnosis of hepatocellular carcinoma, confirmed by clinical chart review and International Classification of Diseases, Tenth Revision (ICD-10) C22.0.
    • Adults, age 18 or older
    • Able to provide informed consent
  • All other interviewees:
    • Advocates who will self-identify as having had HCC.
    • Others who self-identify as either a caregiver or support person of an HCC patient.
        Physicians/Licensed Independent Practitioners, Social Workers, Nurse Navigators, and
        Research Coordinators will all self-identify as being involved in the care of HCC patients.
        Exclusion Criteria:
          -  Unable to speak Spanish or English
          -  West Haven Grade 2 or higher hepatic encephalopathy19 or other cognitive impairment.
          -  Adults unable or unwilling to consent
          -  Individuals who are not yet adults (infants, children, teenagers)
          -  Prisoners
          -  Given that this study is minimal risk and there are no risks to a potential fetus,
             investigators will not exclude pregnant women; however, no data about pregnancy or
             their fetus is being collected

Study details

Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatobiliary Cancer

NCT06260943

University of Miami

28 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.